Confirmation of a new phenotype in an individual with a variant in the last part of exon 30 of CREBBP.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
04 2019
Historique:
received: 23 11 2018
revised: 28 12 2018
accepted: 01 01 2019
pubmed: 10 2 2019
medline: 23 4 2020
entrez: 10 2 2019
Statut: ppublish

Résumé

We report here a novel de novo missense variant affecting the last amino acid of exon 30 of CREBBP [NM_004380, c.5170G>A; p.(Glu1724Lys)] in a 17-year-old boy presenting mild intellectual disability and dysmorphisms but not resembling the phenotype of classical Rubinstein-Taybi syndrome. The patient showed a marked overweight from early infancy on and had cortical heterotopias. Recently, 22 individuals have been reported with missense mutations in the last part of exon 30 and the beginning of exon 31 of CREBBP, showing this new phenotype. This additional case further delineates the genotype-phenotype correlations within the molecular and phenotypic spectrum of variants in CREBBP and EP300.

Identifiants

pubmed: 30737887
doi: 10.1002/ajmg.a.61052
doi:

Substances chimiques

CREB-Binding Protein EC 2.3.1.48
CREBBP protein, human EC 2.3.1.48

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

634-638

Subventions

Organisme : Sardinian Autonomous Region
ID : CRP-59829
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Andrea Angius (A)

Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche (CNR), Monserrato (CA), Italy.

Paolo Uva (P)

Centre for Advanced Studies, Research and Development in Sardinia (CRS4), Science and Technology Park Polaris, Pula (CA), Italy.

Manuela Oppo (M)

Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche (CNR), Monserrato (CA), Italy.
Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Sassari, Italy.

Ivana Persico (I)

Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche (CNR), Monserrato (CA), Italy.

Stefano Onano (S)

Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche (CNR), Monserrato (CA), Italy.
Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Sassari, Italy.

Stefania Olla (S)

Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche (CNR), Monserrato (CA), Italy.

Valentina Pes (V)

Clinica di Neuropsichiatria Infantile, Dipartimento di Scienze Mediche, Chirurgiche e Sperimentali, Università degli Studi di Sassari, Sassari, Italy.

Chiara Perria (C)

Clinica di Neuropsichiatria Infantile, Dipartimento di Scienze Mediche, Chirurgiche e Sperimentali, Università degli Studi di Sassari, Sassari, Italy.

Gianmauro Cuccuru (G)

Centre for Advanced Studies, Research and Development in Sardinia (CRS4), Science and Technology Park Polaris, Pula (CA), Italy.

Rossano Atzeni (R)

Centre for Advanced Studies, Research and Development in Sardinia (CRS4), Science and Technology Park Polaris, Pula (CA), Italy.

Gigliola Serra (G)

Clinica di Neuropsichiatria Infantile, Dipartimento di Scienze Mediche, Chirurgiche e Sperimentali, Università degli Studi di Sassari, Sassari, Italy.

Francesco Cucca (F)

Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche (CNR), Monserrato (CA), Italy.
Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Sassari, Italy.

Stefano Sotgiu (S)

Clinica di Neuropsichiatria Infantile, Dipartimento di Scienze Mediche, Chirurgiche e Sperimentali, Università degli Studi di Sassari, Sassari, Italy.

Raoul C Hennekam (RC)

Department of Pediatrics, Amsterdam UMC location AMC, University of Amsterdam, Amsterdam, the Netherlands.

Laura Crisponi (L)

Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche (CNR), Monserrato (CA), Italy.
Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Sassari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH